Related Experiment Video
Updated: Apr 7, 2026

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Non-transfusion Dependent Thalassemias: A Developing Country Perspective.
Somnath Mukherjee, Rashmi R Das1, Babita Raghuwanshi
1Department of Pediatrics, All India Institute of Medical Sciences, Bhubaneswar - 751019, India. rrdas05@gmail.com.
Non-transfusion-dependent thalassemias (NTDT) are chronic anemias often under-recognized in India. Early diagnosis and management of NTDT are crucial to reduce serious complications and improve patient health outcomes.
Area of Science:
- Hematology
- Genetics
- Public Health
Background:
- Non-transfusion-dependent thalassemias (NTDT) are inherited chronic hemolytic anemias not requiring regular blood transfusions.
- Includes conditions like β-thalassemia intermedia, Hemoglobin E/β-thalassemia, and Hemoglobin H disease.
- May also involve interactions between hemoglobin variants (e.g., HbS, HbC) and alpha/beta thalassemia.
Purpose of the Study:
- To review pathophysiological mechanisms of NTDT.
- To discuss available management options for NTDT.
- To focus on the NTDT perspective in developing countries, specifically India.
Main Methods:
- Literature review focusing on pathophysiology and management of NTDT.
- Analysis of disease burden and complications in the context of developing nations.
- Emphasis on preventive and remedial measures.
Main Results:
- NTDT patients face transfusion-independent complications similar to transfusion-dependent thalassemia.
- These anemias are under-recognized in India, potentially leading to high morbidity.
- Key pathophysiological features include ineffective erythropoiesis, hemolysis, and chronic anemia.
Conclusions:
- Timely diagnosis and appropriate management are essential for reducing NTDT morbidity.
- Patient education is vital for effective disease management.
- Addressing NTDT in developing countries like India requires focused strategies due to high disease burden.
More Related Videos
11:59Detection of Residual Donor Erythroid Progenitor Cells after Hematopoietic Stem Cell Transplantation for Patients with Hemoglobinopathies
Published on: September 6, 2017
05:23Continuous Manual Exchange Transfusion for Patients with Sickle Cell Disease: An Efficient Method to Avoid Iron Overload
Published on: March 14, 2017
Related Concept Videos
Blood Transfusion
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of...
Translation
Translation Produces the Building Blocks of Life
Proteins are...
Drug toxicity: Idiosyncratic Reactions